Literature DB >> 19365163

The treatment of depression in patients with advanced cancer undergoing palliative care.

Annabel Price1, Matthew Hotopf.   

Abstract

PURPOSE OF REVIEW: Depression is a common condition affecting those with advanced cancer, but evidence for effective treatment has been sparse. In recent years, there has been a welcome increase in research activity, with both pharmacological and nonpharmacological treatments being trialled. RECENT
FINDINGS: This review assesses recent studies of pharmacological interventions including antidepressants and psychostimulants and nonpharmacological interventions including cognitive behavioural therapy, supportive expressive group therapy, couples therapy, complex interventions and aromatherapy massage for treatment of depression. Recent published systematic reviews of interventions for depression are also discussed.
SUMMARY: Recent research efforts have paid particular attention to psychological interventions, with cognitive behavioural therapy approaches being most evaluated and showing some encouraging results. Pharmacological interventions remain challenging to assess using rigorous clinical trial methodology, and clinicians still rely upon data derived from studies using general populations and those with less advanced disease or other physical illness. Methodologically sound trials of pharmacological interventions for treatment of depression in advanced disease remains an area of research need.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365163     DOI: 10.1097/SPC.0b013e328325d17a

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  10 in total

Review 1.  [Antidepressants for treatment of depression in palliative patients : a systematic literature review].

Authors:  M Ujeyl; B Müller-Oerlinghausen
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

2.  Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.

Authors:  Marta Peciña; Magdalena Sikora; Erich T Avery; Joseph Heffernan; Susana Peciña; Brian J Mickey; Jon-Kar Zubieta
Journal:  Eur Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 4.600

3.  Identifying tumor patients' depression.

Authors:  Susanne Singer; Anna Brown; Jens Einenkel; Johann Hauss; Andreas Hinz; Andrea Klein; Kirsten Papsdorf; Jens-Uwe Stolzenburg; Elmar Brähler
Journal:  Support Care Cancer       Date:  2010-09-19       Impact factor: 3.603

Review 4.  Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Authors:  Nina Schimmel; Joost J Breeksema; Sanne Y Smith-Apeldoorn; Jolien Veraart; Wim van den Brink; Robert A Schoevers
Journal:  Psychopharmacology (Berl)       Date:  2021-11-23       Impact factor: 4.530

5.  Responding to the Spiritual Needs of Palliative Care Patients: A Randomized Controlled Trial to Test the Effectiveness of the Kibo Therapeutic Interview.

Authors:  Ana Soto-Rubio; Marian Perez-Marin; David Rudilla; Laura Galiana; Amparo Oliver; Miguel Fombuena; Pilar Barreto
Journal:  Front Psychol       Date:  2020-08-21

6.  Depression and chronic diseases: it is time for a synergistic mental health and primary care approach.

Authors:  Boris Voinov; William D Richie; Rahn K Bailey
Journal:  Prim Care Companion CNS Disord       Date:  2013-04-04

7.  Depressive disorder in the last phase of life in patients with cardiovascular disease, cancer, and COPD: data from a 20-year follow-up period in general practice.

Authors:  Franca Warmenhoven; Hans Bor; Peter Lucassen; Kris Vissers; Chris van Weel; Judith Prins; Henk Schers
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

8.  Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients.

Authors:  Wadih Rhondali; Sriram Yennurajalingam; Jeanette Ferrer; Gary Chisholm; Marilene Filbet; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2013-11-16       Impact factor: 3.603

9.  Intervention for depression among palliative care patients and their families: A study protocol for evaluation of a training program for professional care staff.

Authors:  David J Hallford; Marita P McCabe; David Mellor; Tanya E Davison; Denisa L Goldhammer; Kuruvilla George; Shane Storer
Journal:  BMC Palliat Care       Date:  2011-06-13       Impact factor: 3.234

10.  The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial.

Authors:  Marc Serfaty; Michael King; Irwin Nazareth; Adrian Tookman; John Wood; Anna Gola; Trefor Aspden; Kathryn Mannix; Sarah Davis; Stirling Moorey; Louise Jones
Journal:  Trials       Date:  2016-02-29       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.